Basket | Login | Register

 
 
 
 

SS5 Can we move the Alzheimer’s Disease environment towards an earlier diagnosis?

Detailed programme and abstracts

SS5: Can we move the Alzheimer’s Disease environment towards an earlier diagnosis? (Wednesday 2 Nov, 12.15 - 13.15)

DOXFORD Hilary, RODRIGUEZ Octavio, BOADA Mercè, DUMAS Annette

More than 34 million people worldwide have Alzheimer Disease (AD).Current clinical paradigm does not support or emphasize the need for early detection, diagnosis and urgency for action, as soon as symptoms of AD first begin. Focus is still on later clinical stages of the disease.

This creates a barrier to access to available treatments and support services, as well as enrollment in Clinical trials. We need to better understand the obstacles to engagement for early diagnosis and treatment, and successful strategies to overcome them.

MOPEAD project (Models of Patient Engagement for Alzheimer’s Disease), is designed to assess different Patient Engagement models across Europe, to identify efficient approaches of earlier identification of mild AD dementia and prodromal AD patients.

MOPEAD has the potential to contribute to move the AD Environment towards earlier diagnosis to improve identification of appropriate patients for disease modifying therapies.

 

 
 

Last Updated: Tuesday 10 January 2017

 

 
 

Options